Clinical trials
Pituitary ACTH Hypersecretion trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2013 | 3 |
| 2014 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 8 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Corcept Therapeutics | 8 |
| Novartis Pharmaceuticals | 8 |
| Mayo Clinic | 3 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 3 |
| Cortendo AB | 2 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| RECORDATI GROUP | 2 |
| Cedars-Sinai Medical Center | 1 |
| Crinetics Pharmaceuticals Inc. | 1 |
| H. Lundbeck A/S | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pituitary ACTH Hypersecretion | 37 |
| Cushing Syndrome | 13 |
| ACTH Syndrome, Ectopic | 9 |
| Pituitary Diseases | 7 |
| Pituitary Neoplasms | 7 |
| Adrenal Cortex Neoplasms | 5 |
| Acromegaly | 3 |
| Adrenocortical Hyperfunction | 3 |
| Choristoma | 3 |
| Diabetes Mellitus, Type 2 | 3 |
Trials
Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.